TheNote
ViiV Healthcare announces CHMP... Note
GooglePlay AppStore
GSK press releases

ViiV Healthcare announces CHMP positive opinion for Vocabria + Rekambys, the first and only complete long-acting HIV treatment, for adolescents in Europe

Vocabria + Rekambys is the first and only complete long-acting regimen for the treatment of HIV, reducing dosing days from 365 to 6 per year
https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-chmp-positive-opinion-for-vocabria-plus-rekambys-the-first-and-only-complete-long-acting-hiv-treatment-for-adolescents-in-europe/ gsk.com
RSS Hunter RSS Hunter • Dec 16, 2024

Cookies help us deliver our Services. By using our Services or clicking I agree, you agree to our use of cookies .